98%
921
2 minutes
20
Islet transplantation, a form of cell therapy involving the injection of healthy islet cells into the recipient's body for curative treatment of T1DM, often fails due to oxidative stress and inflammatory damage experienced by the transplanted islets. Curcumin, a naturally occurring polyphenol with potent anti-inflammatory and antioxidant properties, has been underutilized in islet protection due to challenges associated with its co-delivery and formulation. In this study, we developed bioadhesive curcumin microspheres (PDA/CUR@SF) by incorporating curcumin into a silk fibroin matrix and subsequently coating it with polydopamine to enhance islet adherence. Silk protein acts as a delivery carrier while polydopamine serves as an adhesive agent; both components synergistically provide anti-inflammatory effects. In vitro experiments demonstrated that PDA/CUR@SF enhances islet resistance against oxidative stress and inflammatory damage by improving cell viability and function. In vivo studies showed that PDA/CUR@SF prolongs stabilization of blood glucose levels in diabetic mice receiving islet transplantation while facilitating faster glucose clearance. Further analysis revealed that PDA/CUR@SF protects transplanted islets through co-grafting and promotes neovascularization. Overall, our findings suggest that PDA/CUR@SF offers a rational approach to improve outcomes in transplantation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804778 | PMC |
http://dx.doi.org/10.1016/j.mtbio.2025.101507 | DOI Listing |
MedComm (2020)
September 2025
Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, Division of Pancreatic Surgery, Department of General Surgery, Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital Sichuan University Chen
The pancreatic islets of Langerhans, which are composed of α, β, δ, ε, and PP cells, orchestrate systemic glucose homeostasis through tightly regulated hormone secretion. Although the precise mechanisms involving β cells in the onset and progression of diabetes have been elucidated and insulin replacement therapy remains the primary treatment modality, the regulatory processes, functions, and specific roles of other pancreatic islet hormones in diabetes continue to be the subject of ongoing investigation. At present, a comprehensive review of the secretion and regulation of pancreatic islet cell hormones as well as the related mechanisms of diabetes is lacking.
View Article and Find Full Text PDFDiabetes Metab J
September 2025
Institute of Medical & Public Health Research, Ilia State University, Tbilisi, Georgia.
Background: The long-term clinical efficacy of intraportal islet transplantation is hampered by islet loss due to inflammation, oxidative stress, and insufficient vascularization. This study explores the venous sac as an alternative implantation site for islet transplantation in large animal models.
Methods: An immunosuppressed, diabetic cynomolgus monkey received allogeneic islet implants in its mesenteric venous sac, with metabolic assessments over 112 days.
Carbohydr Polym
November 2025
Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Electronic address:
Islet transplantation offers a promising therapeutic strategy for type 1 diabetes patients with inadequate glycemic control or severe complications. Islet encapsulation using biocompatible materials presents a potential solution to reduce immune rejection. This study fabricated and characterized Schiff base hydrogels (CMOCs) composed of varying ratios of carboxymethyl chitosan (CMCS) and oxidized carboxymethyl starch (OCMS).
View Article and Find Full Text PDFFront Immunol
September 2025
Chemical and Biological Engineering, Koc University, Istanbul, Türkiye.
Type 1 diabetes (T1D) is characterized by the autoimmune destruction of pancreatic beta cells, resulting in lifelong insulin therapy that falls short of a true cure. Beta cell replacement therapies hold immense potential to restore natural insulin production, but they face significant hurdles such as immune rejection, limited donor availability, and long-term graft survival. In this review, we explore cutting-edge advances in genetic engineering, biomaterials, and machine learning approaches designed to overcome these barriers and enhance the clinical applicability of beta cell therapies.
View Article and Find Full Text PDFWorld J Transplant
September 2025
Department of Anatomy, All India Institute of Medical Sciences, Bhubaneswar 751019, Odisha, India.
Background: Not all islet transplants desirably achieve insulin independence. This can be attributed to the microarchitecture and function of the islets influenced by their dimensions. Large islets enhance insulin secretion through paracrine effects but are more susceptible to hypoxic injury post-transplant, while small islets offer better viability and insulin independence.
View Article and Find Full Text PDF